Patents by Inventor Christopher David Edwards

Christopher David Edwards has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190023707
    Abstract: Compound (I), and pharmaceutically acceptable salts thereof, are inducers of human interferon. Certain discrete and particular dosages of Compound (I) may be particularly useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions, for example allergic rhinitis and allergic asthma.
    Type: Application
    Filed: September 27, 2018
    Publication date: January 24, 2019
    Inventors: Claire Louise AMBERY, Christopher David EDWARDS
  • Patent number: 10112946
    Abstract: Compound (I), and pharmaceutically acceptable salts thereof, are inducers of human interferon. Certain discrete and particular dosages of Compound (I) may be particularly useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions, for example allergic rhinitis and allergic asthma.
    Type: Grant
    Filed: July 19, 2012
    Date of Patent: October 30, 2018
    Assignee: GlaxoSmithKline LLC
    Inventors: Claire Louise Ambery, Christopher David Edwards
  • Publication number: 20140288099
    Abstract: Compound (I), and pharmaceutically acceptable salts thereof, are inducers of human interferon. Certain discrete and particular dosages of Compound (I) may be particularly useful in the treatment of various disorders, for example the treatment of allergic diseases and other inflammatory conditions, for example allergic rhinitis and allergic asthma.
    Type: Application
    Filed: July 19, 2012
    Publication date: September 25, 2014
    Applicant: GLAXOSMITHKLINE LLC
    Inventors: Claire Louise Ambery, Christopher David Edwards